Cargando…

Colorectal cancer screening: the time to act is now

BACKGROUND: Colorectal cancer (CRC) is the third most common cancer and the fourth most common cause of cancer deaths globally. However, there is overwhelming evidence that a large proportion of CRC cases and deaths could be prevented by screening. Nevertheless, CRC screening programmes are offered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brenner, Hermann, Stock, Christian, Hoffmeister, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603638/ https://www.ncbi.nlm.nih.gov/pubmed/26459270 http://dx.doi.org/10.1186/s12916-015-0498-x

Ejemplares similares

Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies
por: Brenner, Hermann, et al.
Publicado: (2014)

Expected long-term impact of screening endoscopy on colorectal cancer incidence: a modelling study
por: Brenner, Hermann, et al.
Publicado: (2016)

Adherence to Physician Recommendations for Surveillance in Opportunistic Colorectal Cancer Screening: The Necessity of Organized Surveillance
por: Stock, Christian, et al.
Publicado: (2013)

Self-Reported Lower Gastrointestinal Endoscopy Use and Changes in Colorectal Cancer Mortality Rates in European Countries
por: Chen, Chen, et al.
Publicado: (2020)

Inter-Physician Variation in Follow-Up Colonoscopies after Screening Colonoscopy
por: Stock, Christian, et al.
Publicado: (2013)

Quantitative SPECT: the time is now
por: Dickson, John, et al.
Publicado: (2019)

Probiotic research in neonates with congenital gastrointestinal surgical conditions – Now is the time
por: Rao, Shripada C., et al.
Publicado: (2018)

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies
por: Niedermaier, Tobias, et al.
Publicado: (2018)

Survival of patients with symptom- and screening-detected colorectal cancer
por: Brenner, Hermann, et al.
Publicado: (2016)

Artificial intelligence—the future is now
por: Trolice, Mark P., et al.
Publicado: (2021)

Creating a Distinct Medication-Use System for Children at the Point of Care: The Time is Now
por: Parrish, Richard, et al.
Publicado: (2015)

Personalized Initial Screening Age for Colorectal Cancer in Individuals at Average Risk
por: Chen, Xuechen, et al.
Publicado: (2023)

International variation in the prevalence of preclinical colorectal cancer: Implications for predictive values of noninvasive screening tests and potential target populations for screening
por: Krilaviciute, Agne, et al.
Publicado: (2017)

Age-specific sequence of colorectal cancer screening options in Germany: A model-based critical evaluation
por: Heisser, Thomas, et al.
Publicado: (2020)

When gold standards are not so golden: prevalence bias in randomized trials on endoscopic colorectal cancer screening
por: Brenner, Hermann, et al.
Publicado: (2023)

Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey
por: Cardoso, Rafael, et al.
Publicado: (2020)

Impact of demographic changes and screening colonoscopy on long-term projection of incident colorectal cancer cases in Germany: A modelling study
por: Heisser, Thomas, et al.
Publicado: (2022)

Ovarian cancer in Morocco: Time to act is now
por: El Bairi, Khalid, et al.
Publicado: (2021)

Head-to-Head Comparison of the Performance of 17 Risk Models for Predicting Presence of Advanced Neoplasms in Colorectal Cancer Screening
por: Peng, Le, et al.
Publicado: (2019)

Effect of Various Invitation Schemes on the Use of Fecal Immunochemical Tests for Colorectal Cancer Screening: Protocol for a Randomized Controlled Trial
por: Gruner, Laura Fiona, et al.
Publicado: (2020)

Long-Acting Injectable Statins—Is It Time for a Paradigm Shift?
por: Tatham, Lee M., et al.
Publicado: (2019)

Strongly Divergent Impact of Adherence Patterns on Efficacy of Colorectal Cancer Screening: The Need to Refine Adherence Statistics
por: Heisser, Thomas, et al.
Publicado: (2021)

Red and Processed Meat Intake, Polygenic Risk Score, and Colorectal Cancer Risk
por: Chen, Xuechen, et al.
Publicado: (2022)

Effects of Alternative Offers of Screening Sigmoidoscopy and Colonoscopy on Utilization and Yield of Endoscopic Screening for Colorectal Neoplasms: Protocol of the DARIO Randomized Trial
por: Schrotz-King, Petra, et al.
Publicado: (2020)

Associations of smoking with early- and late-onset colorectal cancer
por: Li, Hengjing, et al.
Publicado: (2023)

Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening Colonoscopies
por: Heisser, Thomas, et al.
Publicado: (2023)

Treatment Intensification for Low-risk Metastatic Hormone-sensitive Prostate Cancer: The Time Is Now
por: McKay, Rana R.
Publicado: (2022)

Beyond familial risk: deriving risk‐adapted starting ages of screening among people with a family history of colorectal cancer
por: Chen, Xuechen, et al.
Publicado: (2023)

Reducing readmissions in patients with cirrhosis: the time to act is now
por: Patel, Arpan, et al.
Publicado: (2021)

Miniature gastrointestinal endoscopy: Now and the future
por: McGoran, John J, et al.
Publicado: (2019)

Gender differences in colorectal cancer: implications for age at initiation of screening
por: Brenner, H, et al.
Publicado: (2007)

The time to act is now: pseudo-systematic review
por: Ford, Nathan, et al.
Publicado: (2020)

Diabetic foot ulcers – The time to act is now
por: Falhammar, Henrik
Publicado: (2022)

COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now–New Hopes?
por: Vanden Eynde, Jean Jacques
Publicado: (2021)

Pancreatic Cancer From the Patient Perspective: The Time to Act is Now
por: Vitaloni, Marianna, et al.
Publicado: (2022)

Intestinal Stem Cell Imaging in Colorectal Cancer Screening
por: Moossavi, S, et al.
Publicado: (2013)

Assuring the quality of diagnostic testing: The future is now
por: Nkengsong, John, et al.
Publicado: (2016)

‘”Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection
por: Lake, M. Alexandra, et al.
Publicado: (2016)

We need to act now
por: Eisen, Michael B
Publicado: (2020)

Association of Overweight, Obesity, and Recent Weight Loss With Colorectal Cancer Risk
por: Mandic, Marko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1otdqkltdao4cfnou8c7fhaod3